A. J. . Savitz, “Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study”, СТПР, no. 4, pp. 11–19, Dec. 2016.